News About: Pharm. Industry
AstraZeneca headquarters selects Korea as one of most attracting investment countries
AstraZeneca Korea announced recently that Andrew Hauden, vice-president of AstraZeneca's Asia and Pacific regions, is slated to visit his third-time visit to Korea on April 21 following the previous visit of executive...
Pfizer Korea to focus on arthritis drugs as moneymaker
With Pfizer and Pharmacia combining operations on April 16, Pfizer Korea seems like to concentrate its sales on Bextra, Celebrex and Xalatan as new cash cow in the current downturn in the domestic pharmaceutical indus...
Tylenol 1st most favored brand among pain killersJanssen Korea's Tylenol is the first 2003 popular brand in analgesics among young couples in the 20s and 30s including newly-wed people, a recent survey showed.
Korea Market... |
Hanmi wins Korean patent for egg-derived protein drug
Hanmi Pharm said on April 17 that it acquired a patent related to a core technology of producing a variety of high-price protein drugs from a transgenic hen (title: Multinfunctional embryonic reproduction cell line of...
SK3530, a new anti-impotence drug, under clinical studies in UK.
SK Chemical has developed SK3530, a new anti-impotence drug, jointly with In2Gen, a bio-venture company, and put its phase I clinical studies in England from April 23 after completing the pre-clinical studies on Mar. ...
Bulk drug as a stepping stone for further industrial leap.
The Korea New Drug R&D Association (hereinafter called Association) discussed in depth with Director Chang Joon-shik of the KFDA Drug Safety Bureau over the subject of the government support for the bulk drugs and its...
Korea Green Cross to inaugurate new life insurance company
Korea Green Cross Corporation, which was chosen as a final bidder of ailing Daeshin Life Insurance on March 26, is set to apply for the approval of a new company "Green Cross Life Insurance" to the Financial Superviso...
Marketing activities by domestic drug industries on alert.
The National Tax Service (NTS) may reinforce to impose a proof of burdens to the industry for their entertainment expenses, which triggered alert especially to the domestic pharmaceutical companies.
So far the NTS ...
MSD Korea receives good rating in corporate governance
MSD Korea said recently it has ranked 7th in terms of Korea's excellent corporate governance structure, according to a joint survey conducted by Asian Wall Street Journal, Maeil Business Newspaper and Hewitt Associate...
"Factive" inducing foreign capital investment.
For the first time in Korea "Factive", a novel antibiotic agent originally developed by LGCI, has been approved by the U. S. FDA, indicating its high technology of Korea for the new drug manufacture and the sustained ...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
